Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection.

bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases

http://www.ncbi.nlm.nih.gov/pubmed/38353416

Aliénor Xhaard; Constance Delaugerre; Flore Sicre de Fontbrune; Inès Boussen; Jean-Michel Molina; Marie-Laure Chaix; Maud Salmona; Nathalie De Castro

Feb 14, 2024